Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avancen is a medical device company that developed the MOD® (Medication On Demand) device, the first patient-controlled analgesia (PCA) system for oral medication. The MOD device is designed to improve the delivery of PRN (as needed) pain medications in hospital settings by allowing patients to self-administer prescribed oral doses within programmed safety limits. This technology aims to reduce nurse workload, improve patient satisfaction, and ensure more timely pain relief compared to traditional nurse-administered methods. The system utilizes RFID technology to ensure secure patient identification and integrated software for real-time monitoring and electronic health record (EHR) integration. By automating the delivery and documentation of oral analgesics, Avancen aims to enhance patient safety and clinical efficiency in acute care environments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avancen MOD.